ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1499

$1.82M Total Retail Price of All Prescriptions

Rank: 15 out of 1499

668 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 668 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

32% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,014 460 S3 1 4
LEVOTHYROXINE SODIUM 541 305 2 2
FUROSEMIDE 522 287 3 7
AMLODIPINE BESYLATE 520 247 4 6
OXYCODONE HCL 512 81 S2 5 79
PRAVASTATIN SODIUM 486 208 6 18
LISINOPRIL 476 238 7 1
OMEPRAZOLE 443 205 8 5
GABAPENTIN 438 154 9 13
METFORMIN HCL 420 167 10 8
ATENOLOL 400 139 11 21
CRESTOR 389 146 12 34
NEXIUM 383 127 13 28
ZOLPIDEM TARTRATE 361 137 14 23
CYMBALTA 335 66 15 40
OXYCONTIN 304 0 S2 16 99
RANITIDINE HCL 265 100 17 15
MORPHINE SULFATE ER 264 31 S2 18 85
POTASSIUM CHLORIDE 255 122 19 11
CITALOPRAM HBR 232 137 20 14
SIMVASTATIN 221 116 21 3
WARFARIN SODIUM 207 159 22 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 112 23 25
TAMSULOSIN HCL 202 105 24 29
METOPROLOL TARTRATE 197 125 25 10
BUSPIRONE HCL 189 52 26 94
CYCLOBENZAPRINE HCL 189 46 R 26 41
ADVAIR DISKUS 179 71 28 37
TRAZODONE HCL 176 39 29 32
JANUVIA 174 90 30 84
PROMETHAZINE HCL 173 32 R 31 138
METOPROLOL SUCCINATE 164 73 32 20
SINGULAIR 161 44 33 67
JANUMET 159 79 34 226
AMITRIPTYLINE HCL 158 37 R 35 49
ROPINIROLE HCL 155 58 36 55
PROAIR HFA 149 52 37 30
OXYCODONE HCL-ACETAMINOPHEN 149 14 S2 37 81
COMBIVENT 146 33 39 78
ALENDRONATE SODIUM 146 109 39 33
TRAMADOL HCL 144 111 41 16
SPIRONOLACTONE 143 75 42 61
HYDROMORPHONE HCL 139 29 S2 43 189
FLUTICASONE PROPIONATE 135 41 44 31
SERTRALINE HCL 128 79 45 24
TORSEMIDE 127 53 46 149
ATORVASTATIN CALCIUM 125 73 47 17
CARVEDILOL 118 70 48 22
LOSARTAN POTASSIUM 117 40 49 26
PANTOPRAZOLE SODIUM 115 15 50 48
POLYETHYLENE GLYCOL 3350 114 48 51 52
HYDROCHLOROTHIAZIDE 110 77 52 9
ALLOPURINOL 105 56 53 36
CARISOPRODOL 104 16 R 54 71
ISOSORBIDE MONONITRATE ER 104 29 54 51
ENDOCET 102 35 S2 56 111
ESCITALOPRAM OXALATE 99 35 57 76
LOVASTATIN 99 42 57 19
LYRICA 98 34 59 90
MELOXICAM 97 27 60 27
PLAVIX 97 42 60 54
ESTRADIOL 95 23 R 62 130
SUBOXONE 95 0 62 254
CLOPIDOGREL 92 42 64 39
ORPHENADRINE CITRATE 92 0 R 64 277
KLOR-CON 10 90 45 66 112
METHADONE HCL 89 13 S2 67 170
FINASTERIDE 87 59 68 98
NASONEX 85 13 69 198
TIZANIDINE HCL 84 31 70 105
EVISTA 83 26 71 132
PREMARIN 83 11 R 71 139
EXFORGE HCT 81 46 73 315
MONTELUKAST SODIUM 81 24 73 133
LANTUS 79 55 75 46
METOLAZONE 79 45 75 174
INSULIN SYRINGE 78 44 77 102
MIRTAZAPINE 78 57 77 50
TRICOR 78 18 77 103
BYSTOLIC 78 29 77 108
FENTANYL 77 53 S2 81 60
PEN NEEDLE 77 40 81 120
LANTUS SOLOSTAR 76 28 83 89
CELEBREX 76 27 83 77
AMLODIPINE BESYLATE-BENAZEPRIL 75 28 85 109
VENTOLIN HFA 74 40 86 148
METHOCARBAMOL 74 0 R 86 175
CEFUROXIME 73 47 88 163
PREDNISONE 71 27 89 42
OXYBUTYNIN CHLORIDE 71 25 89 95
SAVELLA 70 14 91 297
BACLOFEN 70 12 91 119
PAROXETINE HCL 69 33 93 59
FLUCONAZOLE 68 12 94 190
THEOPHYLLINE ANHYDROUS 65 65 95 238
VERAPAMIL ER 65 18 95 117
NAMENDA 63 50 97 47
ATENOLOL-CHLORTHALIDONE 62 0 98 227
SPIRIVA 62 19 98 44
MECLIZINE HCL 62 22 98 186
DETROL LA 61 32 101 155
PRIMIDONE 61 0 101 218
HYDROXYZINE PAMOATE 60 0 R 103 194
FLUOXETINE HCL 59 31 104 43
LUNESTA 57 14 105 230
DIOVAN HCT 57 32 105 122
METOCLOPRAMIDE HCL 56 16 107 114
FLOVENT HFA 56 0 107 241
METFORMIN HCL ER 55 28 109 53
LIDODERM 55 43 109 123
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 33 109 87
LIPITOR 55 32 109 107
KLOR-CON M10 55 38 109 176
DANTROLENE SODIUM 55 13 109 454
PROPRANOLOL HCL 54 11 115 115
DOXYCYCLINE HYCLATE 53 27 116 106
DOXAZOSIN MESYLATE 52 35 117 104
DIOVAN 50 0 118 58
OPANA ER 50 0 S2 118 268
CHLORZOXAZONE 50 0 R 118 279
IBUPROFEN 50 0 118 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.